| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophils | 66 | 2009 | 194 | 4.950 |
Why?
|
| Muscle, Smooth | 70 | 2004 | 300 | 3.600 |
Why?
|
| Trachea | 65 | 1998 | 245 | 3.040 |
Why?
|
| Bronchi | 45 | 2007 | 225 | 2.120 |
Why?
|
| Muscle Contraction | 57 | 1998 | 256 | 1.960 |
Why?
|
| CD18 Antigens | 14 | 2009 | 22 | 1.640 |
Why?
|
| Phospholipases A | 24 | 2007 | 45 | 1.460 |
Why?
|
| Periodicals as Topic | 8 | 2008 | 168 | 1.300 |
Why?
|
| Asthma | 22 | 2009 | 1039 | 1.250 |
Why?
|
| Cell Adhesion | 25 | 2009 | 416 | 1.210 |
Why?
|
| Bronchial Hyperreactivity | 11 | 2004 | 73 | 1.130 |
Why?
|
| Adrenergic beta-Agonists | 13 | 2007 | 69 | 1.030 |
Why?
|
| Leukotrienes | 8 | 2007 | 20 | 0.870 |
Why?
|
| Platelet Activating Factor | 17 | 2003 | 53 | 0.870 |
Why?
|
| Acetylcholine | 40 | 1997 | 158 | 0.830 |
Why?
|
| Leukotriene Antagonists | 5 | 2007 | 24 | 0.810 |
Why?
|
| Neutrophils | 13 | 2013 | 324 | 0.790 |
Why?
|
| Publishing | 4 | 2008 | 91 | 0.720 |
Why?
|
| National Institutes of Health (U.S.) | 4 | 2005 | 135 | 0.680 |
Why?
|
| Pulmonary Medicine | 4 | 2011 | 51 | 0.680 |
Why?
|
| Dogs | 48 | 2004 | 634 | 0.670 |
Why?
|
| Albuterol | 8 | 2007 | 35 | 0.650 |
Why?
|
| Public Policy | 3 | 2005 | 59 | 0.640 |
Why?
|
| Airway Resistance | 20 | 2004 | 68 | 0.630 |
Why?
|
| Bronchoconstriction | 16 | 2002 | 49 | 0.620 |
Why?
|
| Interleukin-5 | 14 | 2007 | 36 | 0.610 |
Why?
|
| Peer Review, Research | 3 | 2009 | 37 | 0.600 |
Why?
|
| Animals | 135 | 2015 | 28155 | 0.600 |
Why?
|
| Editorial Policies | 2 | 2008 | 33 | 0.560 |
Why?
|
| In Vitro Techniques | 37 | 2010 | 948 | 0.560 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 18 | 2006 | 38 | 0.540 |
Why?
|
| Lung | 16 | 2013 | 1366 | 0.540 |
Why?
|
| Gene Products, tat | 5 | 2014 | 7 | 0.530 |
Why?
|
| Leukotriene C4 | 17 | 2006 | 21 | 0.520 |
Why?
|
| Dose-Response Relationship, Drug | 41 | 2009 | 1914 | 0.520 |
Why?
|
| Phospholipases A2 | 22 | 2013 | 44 | 0.500 |
Why?
|
| Histamine | 17 | 2002 | 116 | 0.480 |
Why?
|
| Peroxidases | 8 | 2001 | 34 | 0.480 |
Why?
|
| Inflammation Mediators | 3 | 2007 | 159 | 0.480 |
Why?
|
| Methacholine Chloride | 13 | 2007 | 61 | 0.460 |
Why?
|
| Cytosol | 12 | 2007 | 193 | 0.460 |
Why?
|
| Cell Movement | 7 | 2009 | 809 | 0.460 |
Why?
|
| Focal Adhesion Kinase 2 | 3 | 2012 | 12 | 0.450 |
Why?
|
| Arachidonate 5-Lipoxygenase | 8 | 2007 | 21 | 0.430 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2008 | 306 | 0.430 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 5 | 2006 | 75 | 0.430 |
Why?
|
| Guinea Pigs | 27 | 2001 | 163 | 0.420 |
Why?
|
| Acute Lung Injury | 5 | 2013 | 68 | 0.420 |
Why?
|
| Antigens, Helminth | 6 | 1998 | 20 | 0.410 |
Why?
|
| Humans | 126 | 2015 | 93515 | 0.410 |
Why?
|
| Respiratory Hypersensitivity | 5 | 2007 | 36 | 0.410 |
Why?
|
| Tuberculosis, Pulmonary | 6 | 1997 | 59 | 0.400 |
Why?
|
| Androstadienes | 6 | 2007 | 72 | 0.390 |
Why?
|
| Swine | 16 | 1996 | 588 | 0.380 |
Why?
|
| Sympathetic Nervous System | 10 | 1990 | 99 | 0.380 |
Why?
|
| Journal Impact Factor | 2 | 2009 | 15 | 0.380 |
Why?
|
| Phosphorylation | 18 | 2014 | 1133 | 0.380 |
Why?
|
| Acetylcholinesterase | 5 | 1992 | 42 | 0.360 |
Why?
|
| Intercellular Adhesion Molecule-1 | 8 | 2013 | 76 | 0.350 |
Why?
|
| Immunization | 6 | 1996 | 154 | 0.350 |
Why?
|
| Macrophage-1 Antigen | 5 | 2007 | 18 | 0.350 |
Why?
|
| Serotonin | 12 | 1998 | 209 | 0.340 |
Why?
|
| Potassium Chloride | 11 | 1997 | 75 | 0.340 |
Why?
|
| Annexin A1 | 2 | 2007 | 5 | 0.340 |
Why?
|
| Parasympathetic Nervous System | 8 | 1991 | 33 | 0.340 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2012 | 555 | 0.340 |
Why?
|
| Integrins | 8 | 2007 | 79 | 0.330 |
Why?
|
| Isometric Contraction | 5 | 1995 | 34 | 0.330 |
Why?
|
| Respiratory Mechanics | 1 | 2011 | 108 | 0.320 |
Why?
|
| Urban Health | 4 | 1997 | 55 | 0.320 |
Why?
|
| Pneumonia | 6 | 2015 | 193 | 0.310 |
Why?
|
| Transduction, Genetic | 4 | 2007 | 160 | 0.310 |
Why?
|
| ras Proteins | 4 | 2007 | 132 | 0.310 |
Why?
|
| Kinetics | 18 | 2003 | 1492 | 0.300 |
Why?
|
| Cysteine | 2 | 2007 | 145 | 0.290 |
Why?
|
| Fibronectins | 3 | 2001 | 100 | 0.290 |
Why?
|
| Health Policy | 5 | 1997 | 206 | 0.290 |
Why?
|
| Chemotaxis, Leukocyte | 5 | 2007 | 39 | 0.290 |
Why?
|
| Cells, Cultured | 21 | 2015 | 2850 | 0.290 |
Why?
|
| Anti-Inflammatory Agents | 6 | 2007 | 353 | 0.290 |
Why?
|
| Photography | 1 | 2008 | 40 | 0.290 |
Why?
|
| Norepinephrine | 16 | 1992 | 169 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2002 | 216 | 0.290 |
Why?
|
| Male | 88 | 2012 | 44557 | 0.290 |
Why?
|
| Lysophosphatidylcholines | 3 | 2007 | 17 | 0.280 |
Why?
|
| Bronchoalveolar Lavage Fluid | 8 | 2012 | 133 | 0.280 |
Why?
|
| Mast Cells | 7 | 1998 | 96 | 0.270 |
Why?
|
| Capsaicin | 8 | 1997 | 43 | 0.270 |
Why?
|
| Tetradecanoylphorbol Acetate | 4 | 2002 | 122 | 0.260 |
Why?
|
| Ascaris suum | 5 | 1998 | 7 | 0.260 |
Why?
|
| Ribonucleases | 4 | 1996 | 92 | 0.260 |
Why?
|
| Enzyme Inhibitors | 9 | 2015 | 641 | 0.260 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2014 | 282 | 0.250 |
Why?
|
| Inflammation | 7 | 2012 | 1050 | 0.250 |
Why?
|
| Respiratory Physiological Phenomena | 7 | 2004 | 49 | 0.250 |
Why?
|
| Respiratory System | 7 | 1994 | 117 | 0.250 |
Why?
|
| Electric Stimulation | 19 | 1997 | 344 | 0.250 |
Why?
|
| Lipoxygenase Inhibitors | 10 | 2007 | 36 | 0.240 |
Why?
|
| Heart Diseases | 1 | 2008 | 257 | 0.240 |
Why?
|
| Immunomagnetic Separation | 1 | 2006 | 8 | 0.240 |
Why?
|
| Churg-Strauss Syndrome | 2 | 2003 | 9 | 0.240 |
Why?
|
| Interleukin-2 | 3 | 1996 | 244 | 0.230 |
Why?
|
| Aging | 7 | 1994 | 727 | 0.230 |
Why?
|
| Calcium Channels | 1 | 2007 | 180 | 0.230 |
Why?
|
| Forecasting | 3 | 2011 | 293 | 0.230 |
Why?
|
| Indomethacin | 11 | 2001 | 58 | 0.220 |
Why?
|
| Leukocytes | 3 | 2013 | 210 | 0.220 |
Why?
|
| Group V Phospholipases A2 | 7 | 2010 | 9 | 0.220 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2004 | 12 | 0.220 |
Why?
|
| Critical Care | 3 | 1998 | 444 | 0.220 |
Why?
|
| Radio Waves | 1 | 2004 | 20 | 0.210 |
Why?
|
| Group IV Phospholipases A2 | 8 | 2007 | 9 | 0.210 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 626 | 0.210 |
Why?
|
| Receptors, Muscarinic | 4 | 1997 | 42 | 0.210 |
Why?
|
| Endothelial Cells | 5 | 2015 | 477 | 0.210 |
Why?
|
| Receptors, Very Late Antigen | 2 | 1994 | 6 | 0.210 |
Why?
|
| Pyridinium Compounds | 3 | 2003 | 9 | 0.210 |
Why?
|
| CD11b Antigen | 5 | 2007 | 35 | 0.210 |
Why?
|
| Leukotriene B4 | 4 | 2007 | 16 | 0.200 |
Why?
|
| Histamine Release | 5 | 1989 | 53 | 0.200 |
Why?
|
| Epoxy Compounds | 1 | 2003 | 10 | 0.200 |
Why?
|
| Heterocyclic Compounds | 1 | 2003 | 19 | 0.200 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2015 | 147 | 0.200 |
Why?
|
| Eosinophil Peroxidase | 8 | 2007 | 14 | 0.200 |
Why?
|
| HIV | 1 | 2003 | 47 | 0.200 |
Why?
|
| Blood Proteins | 4 | 1996 | 145 | 0.200 |
Why?
|
| Allergens | 3 | 1999 | 189 | 0.200 |
Why?
|
| United States | 16 | 2011 | 7622 | 0.190 |
Why?
|
| Microscopy, Video | 3 | 2002 | 36 | 0.190 |
Why?
|
| Public Health Administration | 4 | 1997 | 19 | 0.180 |
Why?
|
| Genes, ras | 1 | 2002 | 97 | 0.180 |
Why?
|
| Female | 62 | 2015 | 48702 | 0.180 |
Why?
|
| Recombinant Proteins | 7 | 2010 | 988 | 0.180 |
Why?
|
| Arachidonic Acid | 11 | 2006 | 62 | 0.180 |
Why?
|
| Endothelins | 2 | 1992 | 26 | 0.180 |
Why?
|
| Tuberculosis | 4 | 1989 | 124 | 0.180 |
Why?
|
| Calcium | 8 | 2003 | 1176 | 0.180 |
Why?
|
| Long-Term Care | 2 | 1999 | 63 | 0.180 |
Why?
|
| Sympathomimetics | 3 | 1989 | 12 | 0.180 |
Why?
|
| Receptors, Lymphocyte Homing | 3 | 1996 | 11 | 0.180 |
Why?
|
| Myosins | 2 | 1993 | 86 | 0.180 |
Why?
|
| Lipopolysaccharides | 6 | 2015 | 301 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 11 | 2015 | 3435 | 0.170 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2001 | 9 | 0.170 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2003 | 289 | 0.170 |
Why?
|
| Respiration, Artificial | 4 | 2012 | 423 | 0.170 |
Why?
|
| Vagus Nerve | 7 | 1990 | 45 | 0.170 |
Why?
|
| Glucocorticoids | 3 | 2005 | 362 | 0.170 |
Why?
|
| PubMed | 3 | 2005 | 16 | 0.170 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2001 | 22 | 0.170 |
Why?
|
| Catheter Ablation | 1 | 2004 | 345 | 0.170 |
Why?
|
| Down-Regulation | 1 | 2002 | 524 | 0.170 |
Why?
|
| Signal Transduction | 8 | 2015 | 3502 | 0.160 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 3 | 2006 | 9 | 0.160 |
Why?
|
| Immunization, Passive | 2 | 1997 | 68 | 0.160 |
Why?
|
| Adrenergic beta-Antagonists | 5 | 1989 | 112 | 0.160 |
Why?
|
| Cats | 7 | 1998 | 285 | 0.160 |
Why?
|
| Bronchial Provocation Tests | 1 | 1999 | 24 | 0.160 |
Why?
|
| Cell Adhesion Molecules | 3 | 2000 | 174 | 0.150 |
Why?
|
| Th2 Cells | 3 | 2009 | 149 | 0.150 |
Why?
|
| Ovalbumin | 5 | 2007 | 102 | 0.150 |
Why?
|
| Antigens | 6 | 2009 | 224 | 0.150 |
Why?
|
| Cyclosporine | 2 | 1998 | 241 | 0.150 |
Why?
|
| Blotting, Western | 9 | 2008 | 784 | 0.150 |
Why?
|
| Research Personnel | 2 | 2009 | 82 | 0.140 |
Why?
|
| Hospitals, Community | 1 | 1998 | 33 | 0.140 |
Why?
|
| Isoproterenol | 7 | 1994 | 57 | 0.140 |
Why?
|
| Receptors, Tachykinin | 2 | 1995 | 8 | 0.140 |
Why?
|
| Cyclooxygenase Inhibitors | 4 | 1996 | 38 | 0.140 |
Why?
|
| Chemokine CCL11 | 4 | 2007 | 11 | 0.140 |
Why?
|
| Methacholine Compounds | 11 | 1994 | 16 | 0.140 |
Why?
|
| Atropine | 10 | 1996 | 53 | 0.140 |
Why?
|
| Physical Exertion | 2 | 1988 | 38 | 0.140 |
Why?
|
| Health Resources | 1 | 1998 | 80 | 0.140 |
Why?
|
| Serum Albumin, Bovine | 4 | 2007 | 47 | 0.130 |
Why?
|
| Spermatic Cord Torsion | 1 | 1997 | 4 | 0.130 |
Why?
|
| Adrenergic alpha-Agonists | 4 | 1986 | 31 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 85 | 0.130 |
Why?
|
| Phosphodiesterase Inhibitors | 5 | 2006 | 30 | 0.130 |
Why?
|
| Neuropeptides | 3 | 2012 | 114 | 0.130 |
Why?
|
| Tachyphylaxis | 4 | 1991 | 14 | 0.130 |
Why?
|
| RNA, Messenger | 4 | 2010 | 2026 | 0.130 |
Why?
|
| Muscle Relaxation | 4 | 1997 | 15 | 0.130 |
Why?
|
| Hypersensitivity, Immediate | 4 | 2007 | 64 | 0.130 |
Why?
|
| Testis | 1 | 1997 | 148 | 0.130 |
Why?
|
| Rhinitis, Allergic, Seasonal | 2 | 1997 | 179 | 0.130 |
Why?
|
| Hypersensitivity | 4 | 2007 | 162 | 0.130 |
Why?
|
| Pertussis Toxin | 3 | 2007 | 31 | 0.120 |
Why?
|
| Fetal Blood | 2 | 1995 | 95 | 0.120 |
Why?
|
| Cytochalasin B | 6 | 2003 | 19 | 0.120 |
Why?
|
| Parasympathomimetics | 4 | 1992 | 7 | 0.120 |
Why?
|
| Muscle Tonus | 5 | 1997 | 16 | 0.120 |
Why?
|
| Homeostasis | 3 | 1993 | 460 | 0.120 |
Why?
|
| Epinephrine | 5 | 1992 | 92 | 0.120 |
Why?
|
| Receptors, Adrenergic, beta | 4 | 1998 | 68 | 0.120 |
Why?
|
| Physostigmine | 5 | 1997 | 14 | 0.120 |
Why?
|
| Mice | 17 | 2015 | 12269 | 0.120 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 2 | 2007 | 3 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 2365 | 0.120 |
Why?
|
| Interleukin-8 | 2 | 2015 | 88 | 0.120 |
Why?
|
| Isoenzymes | 6 | 2006 | 272 | 0.120 |
Why?
|
| Endothelium, Vascular | 5 | 2013 | 436 | 0.120 |
Why?
|
| Anti-Asthmatic Agents | 1 | 1997 | 93 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 1998 | 394 | 0.120 |
Why?
|
| Enzyme Activation | 10 | 2014 | 674 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 4 | 2006 | 66 | 0.120 |
Why?
|
| Critical Illness | 1 | 1998 | 343 | 0.120 |
Why?
|
| Ischemia | 1 | 1997 | 253 | 0.120 |
Why?
|
| Lung Injury | 2 | 2015 | 59 | 0.120 |
Why?
|
| Epithelial Cells | 4 | 2007 | 700 | 0.120 |
Why?
|
| Dimethylphenylpiperazinium Iodide | 6 | 1989 | 8 | 0.110 |
Why?
|
| Lipoxins | 1 | 2015 | 2 | 0.110 |
Why?
|
| Chemokines, CC | 3 | 2004 | 36 | 0.110 |
Why?
|
| Hyaluronic Acid | 1 | 1995 | 53 | 0.110 |
Why?
|
| Local Government | 2 | 1997 | 6 | 0.110 |
Why?
|
| Benzoquinones | 2 | 2007 | 26 | 0.110 |
Why?
|
| Policy Making | 2 | 2005 | 61 | 0.110 |
Why?
|
| Virulence Factors, Bordetella | 2 | 2001 | 25 | 0.110 |
Why?
|
| Nitriles | 3 | 2006 | 154 | 0.110 |
Why?
|
| Muscle Development | 5 | 1993 | 39 | 0.110 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 3 | 1995 | 6 | 0.110 |
Why?
|
| Up-Regulation | 8 | 2007 | 730 | 0.110 |
Why?
|
| Catecholamines | 3 | 1989 | 91 | 0.110 |
Why?
|
| Epithelium | 9 | 1997 | 316 | 0.100 |
Why?
|
| Fluticasone | 4 | 2007 | 31 | 0.100 |
Why?
|
| Hematopoiesis | 1 | 1995 | 183 | 0.100 |
Why?
|
| Organometallic Compounds | 1 | 2015 | 139 | 0.100 |
Why?
|
| Iloprost | 2 | 2012 | 14 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 1994 | 39 | 0.100 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2014 | 56 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 1995 | 292 | 0.100 |
Why?
|
| Leukocyte Count | 4 | 1999 | 210 | 0.100 |
Why?
|
| Blood Cells | 1 | 1993 | 32 | 0.100 |
Why?
|
| Cell Communication | 2 | 1993 | 216 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2003 | 367 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2007 | 688 | 0.100 |
Why?
|
| Autonomic Nervous System | 3 | 1998 | 67 | 0.100 |
Why?
|
| Respiratory Tract Diseases | 3 | 2003 | 45 | 0.100 |
Why?
|
| Receptors, Adrenergic, alpha | 3 | 1982 | 15 | 0.100 |
Why?
|
| Receptors, Adrenergic | 3 | 1982 | 14 | 0.100 |
Why?
|
| Analysis of Variance | 5 | 2011 | 884 | 0.100 |
Why?
|
| Protein Conformation | 3 | 2007 | 914 | 0.100 |
Why?
|
| Antitubercular Agents | 5 | 1997 | 61 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2015 | 299 | 0.090 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1995 | 319 | 0.090 |
Why?
|
| Macrophages, Alveolar | 1 | 1993 | 66 | 0.090 |
Why?
|
| Stress, Mechanical | 5 | 2013 | 248 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2007 | 123 | 0.090 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 4 | 1989 | 5 | 0.090 |
Why?
|
| Phenyl Ethers | 5 | 1996 | 13 | 0.090 |
Why?
|
| Acetamides | 5 | 1996 | 26 | 0.090 |
Why?
|
| Neurotransmitter Agents | 2 | 1993 | 102 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 8 | 2010 | 1395 | 0.090 |
Why?
|
| Prostaglandins F | 3 | 1987 | 12 | 0.090 |
Why?
|
| Shock, Hemorrhagic | 1 | 2011 | 12 | 0.090 |
Why?
|
| Microtubules | 1 | 2012 | 134 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 1995 | 663 | 0.090 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2012 | 57 | 0.090 |
Why?
|
| Leukemia, Myeloid | 1 | 1993 | 240 | 0.090 |
Why?
|
| Capillary Permeability | 1 | 2012 | 131 | 0.090 |
Why?
|
| Peroxidase | 4 | 2012 | 54 | 0.090 |
Why?
|
| Molecular Sequence Data | 5 | 2014 | 2910 | 0.090 |
Why?
|
| Drug Synergism | 5 | 2004 | 315 | 0.090 |
Why?
|
| Time Factors | 9 | 2010 | 5410 | 0.090 |
Why?
|
| Pulmonary Circulation | 2 | 1991 | 92 | 0.090 |
Why?
|
| Cell Culture Techniques | 3 | 2002 | 197 | 0.090 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 313 | 0.090 |
Why?
|
| Heart Arrest | 1 | 2015 | 311 | 0.090 |
Why?
|
| Propranolol | 6 | 1994 | 43 | 0.090 |
Why?
|
| Leukotriene D4 | 2 | 2009 | 2 | 0.090 |
Why?
|
| Bronchial Spasm | 2 | 1989 | 12 | 0.080 |
Why?
|
| Adult | 19 | 2007 | 27918 | 0.080 |
Why?
|
| Hypothermia, Induced | 1 | 2011 | 90 | 0.080 |
Why?
|
| Superoxides | 3 | 2003 | 75 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2012 | 276 | 0.080 |
Why?
|
| Cell Survival | 7 | 2014 | 1004 | 0.080 |
Why?
|
| Cytokines | 4 | 2015 | 863 | 0.080 |
Why?
|
| Vasoconstriction | 2 | 1990 | 88 | 0.080 |
Why?
|
| Respiratory Tract Infections | 1 | 2011 | 110 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 1993 | 352 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2012 | 246 | 0.080 |
Why?
|
| Perfusion | 5 | 1998 | 260 | 0.080 |
Why?
|
| Respiration | 5 | 1990 | 269 | 0.080 |
Why?
|
| Airway Obstruction | 1 | 2011 | 113 | 0.080 |
Why?
|
| Disease Models, Animal | 5 | 2015 | 2495 | 0.080 |
Why?
|
| Receptors, Leukotriene | 2 | 2001 | 10 | 0.080 |
Why?
|
| Cholinesterase Inhibitors | 3 | 1997 | 45 | 0.080 |
Why?
|
| Science | 1 | 2009 | 36 | 0.080 |
Why?
|
| Peptides | 2 | 2007 | 656 | 0.080 |
Why?
|
| Egtazic Acid | 2 | 2007 | 32 | 0.080 |
Why?
|
| Cell Separation | 4 | 2005 | 200 | 0.070 |
Why?
|
| Vasomotor System | 1 | 1989 | 12 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2012 | 467 | 0.070 |
Why?
|
| Isotonic Contraction | 1 | 1989 | 1 | 0.070 |
Why?
|
| Health | 1 | 1989 | 27 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2014 | 2012 | 0.070 |
Why?
|
| Hypotension | 2 | 1989 | 72 | 0.070 |
Why?
|
| Oxygen Consumption | 2 | 1990 | 238 | 0.070 |
Why?
|
| Diabetic Neuropathies | 1 | 1988 | 42 | 0.070 |
Why?
|
| Antibody Formation | 1 | 1989 | 169 | 0.070 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 1985 | 0.070 |
Why?
|
| Eosinophil Granule Proteins | 4 | 1996 | 19 | 0.070 |
Why?
|
| Congresses as Topic | 1 | 2008 | 124 | 0.070 |
Why?
|
| Rats | 5 | 1997 | 4072 | 0.070 |
Why?
|
| Tyrosine | 1 | 2008 | 131 | 0.070 |
Why?
|
| Blood Platelets | 1 | 1988 | 150 | 0.070 |
Why?
|
| Cyclopropanes | 1 | 2007 | 26 | 0.070 |
Why?
|
| Random Allocation | 3 | 2012 | 307 | 0.070 |
Why?
|
| Protein Kinase C | 4 | 2005 | 261 | 0.070 |
Why?
|
| Osmolar Concentration | 3 | 2003 | 168 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2007 | 79 | 0.070 |
Why?
|
| Acetates | 1 | 2007 | 60 | 0.070 |
Why?
|
| Annexins | 2 | 2005 | 6 | 0.070 |
Why?
|
| Sulfides | 1 | 2007 | 68 | 0.070 |
Why?
|
| Hyperventilation | 1 | 1987 | 13 | 0.070 |
Why?
|
| Cyclic AMP | 7 | 2006 | 276 | 0.060 |
Why?
|
| Interleukin-13 Receptor alpha2 Subunit | 1 | 2007 | 5 | 0.060 |
Why?
|
| Lymphocyte Activation | 4 | 2000 | 797 | 0.060 |
Why?
|
| Quinolines | 1 | 2007 | 85 | 0.060 |
Why?
|
| Phosphatidylethanolamines | 1 | 2007 | 16 | 0.060 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2007 | 5 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2011 | 621 | 0.060 |
Why?
|
| Rest | 1 | 1987 | 50 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 1028 | 0.060 |
Why?
|
| Interleukin-13 | 1 | 2007 | 41 | 0.060 |
Why?
|
| Immunoglobulin E | 2 | 1997 | 148 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 122 | 0.060 |
Why?
|
| Research Support as Topic | 1 | 1987 | 89 | 0.060 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1987 | 85 | 0.060 |
Why?
|
| Bronchography | 4 | 1991 | 10 | 0.060 |
Why?
|
| Stimulation, Chemical | 5 | 1993 | 57 | 0.060 |
Why?
|
| Lysophospholipids | 1 | 2007 | 67 | 0.060 |
Why?
|
| Salmeterol Xinafoate | 5 | 2006 | 16 | 0.060 |
Why?
|
| GTP-Binding Proteins | 1 | 2007 | 147 | 0.060 |
Why?
|
| Piperidines | 2 | 2001 | 165 | 0.060 |
Why?
|
| Ascaris | 4 | 1989 | 5 | 0.060 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 3 | 1995 | 8 | 0.060 |
Why?
|
| Solubility | 1 | 2007 | 187 | 0.060 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 1997 | 25 | 0.060 |
Why?
|
| Length of Stay | 3 | 1999 | 828 | 0.060 |
Why?
|
| Hospitalization | 3 | 1999 | 937 | 0.060 |
Why?
|
| Coronary Disease | 1 | 1987 | 223 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 4 | 2010 | 436 | 0.060 |
Why?
|
| Child | 7 | 1997 | 7355 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2011 | 624 | 0.060 |
Why?
|
| Health Facilities | 2 | 1985 | 38 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 2 | 2003 | 200 | 0.060 |
Why?
|
| Lung Diseases | 3 | 2004 | 283 | 0.060 |
Why?
|
| Survival Analysis | 2 | 1999 | 1524 | 0.060 |
Why?
|
| Integrin beta Chains | 1 | 2005 | 3 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2007 | 603 | 0.060 |
Why?
|
| Mucus | 2 | 2003 | 19 | 0.060 |
Why?
|
| Animals, Newborn | 4 | 1997 | 522 | 0.060 |
Why?
|
| Cell Division | 3 | 1995 | 693 | 0.050 |
Why?
|
| Middle Aged | 10 | 2007 | 27573 | 0.050 |
Why?
|
| Propanolamines | 1 | 1984 | 21 | 0.050 |
Why?
|
| Software | 1 | 2008 | 670 | 0.050 |
Why?
|
| Butadienes | 2 | 2001 | 33 | 0.050 |
Why?
|
| Biomechanical Phenomena | 4 | 1989 | 489 | 0.050 |
Why?
|
| Lymphocytes | 2 | 2003 | 454 | 0.050 |
Why?
|
| Cell Migration Inhibition | 1 | 2003 | 8 | 0.050 |
Why?
|
| Bronchodilator Agents | 1 | 2004 | 70 | 0.050 |
Why?
|
| Cell Membrane | 5 | 2009 | 664 | 0.050 |
Why?
|
| Isoniazid | 2 | 1985 | 8 | 0.050 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2004 | 27 | 0.050 |
Why?
|
| Risk Factors | 4 | 1999 | 5899 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 102 | 0.050 |
Why?
|
| Actins | 2 | 2010 | 467 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2003 | 140 | 0.050 |
Why?
|
| Eicosanoids | 3 | 1999 | 17 | 0.050 |
Why?
|
| Lymphatic System | 2 | 1993 | 54 | 0.050 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 1994 | 39 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 1995 | 319 | 0.050 |
Why?
|
| Sympatholytics | 1 | 1982 | 5 | 0.050 |
Why?
|
| Artifacts | 1 | 2004 | 243 | 0.050 |
Why?
|
| Temperature | 1 | 2004 | 424 | 0.050 |
Why?
|
| Tachykinins | 2 | 1993 | 13 | 0.050 |
Why?
|
| Receptors, Neurotransmitter | 2 | 1993 | 24 | 0.050 |
Why?
|
| Cell Degranulation | 2 | 1999 | 14 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 422 | 0.050 |
Why?
|
| Dinoprost | 3 | 1987 | 27 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2002 | 302 | 0.050 |
Why?
|
| Resuscitation | 2 | 2015 | 130 | 0.050 |
Why?
|
| Immunoblotting | 3 | 2011 | 273 | 0.050 |
Why?
|
| Tidal Volume | 5 | 2013 | 61 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1993 | 159 | 0.050 |
Why?
|
| Type C Phospholipases | 1 | 2001 | 26 | 0.040 |
Why?
|
| Electric Impedance | 2 | 2012 | 115 | 0.040 |
Why?
|
| Ganglia, Parasympathetic | 1 | 1981 | 1 | 0.040 |
Why?
|
| Flow Cytometry | 3 | 2005 | 712 | 0.040 |
Why?
|
| Cattle | 3 | 1997 | 397 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2003 | 1546 | 0.040 |
Why?
|
| Okadaic Acid | 1 | 2001 | 10 | 0.040 |
Why?
|
| Butyrophenones | 1 | 2001 | 5 | 0.040 |
Why?
|
| Pulmonary Artery | 3 | 2012 | 333 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 1993 | 232 | 0.040 |
Why?
|
| Azepines | 1 | 2001 | 28 | 0.040 |
Why?
|
| Phenylephrine | 4 | 1990 | 33 | 0.040 |
Why?
|
| Forced Expiratory Volume | 2 | 1999 | 136 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2013 | 2121 | 0.040 |
Why?
|
| Dinoprostone | 2 | 1998 | 71 | 0.040 |
Why?
|
| Hemodynamics | 4 | 2015 | 713 | 0.040 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 3 | 2006 | 10 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 1997 | 759 | 0.040 |
Why?
|
| Parasympatholytics | 2 | 1991 | 17 | 0.040 |
Why?
|
| Organ Size | 2 | 2009 | 362 | 0.040 |
Why?
|
| Drug Interactions | 2 | 1993 | 239 | 0.040 |
Why?
|
| Data Collection | 2 | 1993 | 370 | 0.040 |
Why?
|
| Antibodies | 2 | 2007 | 348 | 0.040 |
Why?
|
| Triazoles | 1 | 2001 | 110 | 0.040 |
Why?
|
| CD3 Complex | 1 | 2000 | 135 | 0.040 |
Why?
|
| Integrin alpha4beta1 | 2 | 1996 | 2 | 0.040 |
Why?
|
| Substance P | 2 | 1997 | 62 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2000 | 481 | 0.040 |
Why?
|
| Tuberculosis, Miliary | 1 | 1979 | 4 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2001 | 142 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 304 | 0.040 |
Why?
|
| Lung Compliance | 4 | 2009 | 15 | 0.040 |
Why?
|
| Skin Tests | 1 | 1999 | 46 | 0.040 |
Why?
|
| Steroids | 1 | 2001 | 168 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2000 | 124 | 0.040 |
Why?
|
| Protein Transport | 3 | 2006 | 438 | 0.040 |
Why?
|
| Integrin beta1 | 1 | 1999 | 34 | 0.040 |
Why?
|
| Piperazines | 1 | 1981 | 284 | 0.040 |
Why?
|
| Hydroxyurea | 2 | 1997 | 231 | 0.040 |
Why?
|
| Polylysine | 2 | 1997 | 32 | 0.040 |
Why?
|
| Peptides, Cyclic | 1 | 1999 | 40 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 1999 | 72 | 0.040 |
Why?
|
| Cell Count | 1 | 1999 | 197 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 1103 | 0.040 |
Why?
|
| Receptors, IgE | 1 | 1999 | 6 | 0.040 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1979 | 24 | 0.040 |
Why?
|
| Surgical Flaps | 1 | 2001 | 252 | 0.040 |
Why?
|
| Ventilator Weaning | 1 | 1999 | 40 | 0.040 |
Why?
|
| Cost Control | 1 | 1998 | 43 | 0.040 |
Why?
|
| Tryptophan | 1 | 1999 | 105 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1998 | 32 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 136 | 0.040 |
Why?
|
| Reimbursement Mechanisms | 1 | 1998 | 40 | 0.040 |
Why?
|
| Base Sequence | 2 | 1993 | 2220 | 0.040 |
Why?
|
| Receptors, IgG | 1 | 1998 | 68 | 0.030 |
Why?
|
| Ligands | 3 | 2009 | 476 | 0.030 |
Why?
|
| Resuscitation Orders | 1 | 1998 | 65 | 0.030 |
Why?
|
| Mortality | 1 | 1999 | 156 | 0.030 |
Why?
|
| Methysergide | 2 | 1988 | 6 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1997 | 1245 | 0.030 |
Why?
|
| Budgets | 1 | 1997 | 10 | 0.030 |
Why?
|
| Pulmonary Stretch Receptors | 1 | 1997 | 2 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 1999 | 175 | 0.030 |
Why?
|
| Respiration Disorders | 2 | 1993 | 42 | 0.030 |
Why?
|
| Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide | 1 | 1997 | 2 | 0.030 |
Why?
|
| Hospital Costs | 1 | 1998 | 116 | 0.030 |
Why?
|
| Prostaglandin Antagonists | 1 | 1997 | 7 | 0.030 |
Why?
|
| Receptors, Prostaglandin E | 1 | 1997 | 4 | 0.030 |
Why?
|
| Xanthones | 1 | 1997 | 10 | 0.030 |
Why?
|
| Cell Differentiation | 3 | 2003 | 1621 | 0.030 |
Why?
|
| Protein Isoforms | 3 | 2005 | 295 | 0.030 |
Why?
|
| Oxygen | 4 | 1992 | 769 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 1997 | 72 | 0.030 |
Why?
|
| Antigens, CD | 2 | 2000 | 476 | 0.030 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 1998 | 36 | 0.030 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 1997 | 20 | 0.030 |
Why?
|
| Muscarinic Agonists | 1 | 1997 | 22 | 0.030 |
Why?
|
| Biphenyl Compounds | 2 | 1997 | 60 | 0.030 |
Why?
|
| Tosyl Compounds | 1 | 1997 | 13 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 1997 | 203 | 0.030 |
Why?
|
| Aerosols | 2 | 1994 | 44 | 0.030 |
Why?
|
| Bacillus cereus | 1 | 1977 | 9 | 0.030 |
Why?
|
| Gentamicins | 1 | 1977 | 21 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 366 | 0.030 |
Why?
|
| Respiratory Muscles | 1 | 1997 | 27 | 0.030 |
Why?
|
| Administration, Topical | 2 | 1999 | 80 | 0.030 |
Why?
|
| Immunity, Active | 2 | 1991 | 8 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 1997 | 102 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2001 | 9099 | 0.030 |
Why?
|
| Aged | 6 | 1999 | 20434 | 0.030 |
Why?
|
| Glycoproteins | 1 | 1998 | 220 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 1997 | 285 | 0.030 |
Why?
|
| Heart Failure | 1 | 1987 | 1386 | 0.030 |
Why?
|
| Arachidonic Acids | 2 | 1999 | 36 | 0.030 |
Why?
|
| Hypoxia | 3 | 1987 | 675 | 0.030 |
Why?
|
| Heart Rate | 3 | 1988 | 505 | 0.030 |
Why?
|
| Protein Binding | 2 | 2014 | 1534 | 0.030 |
Why?
|
| Acetophenones | 2 | 1993 | 27 | 0.030 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1996 | 62 | 0.030 |
Why?
|
| Tromethamine | 1 | 1995 | 3 | 0.030 |
Why?
|
| Rabbits | 2 | 1996 | 618 | 0.030 |
Why?
|
| Biological Assay | 2 | 1993 | 82 | 0.030 |
Why?
|
| Adolescent | 5 | 1997 | 9606 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1995 | 42 | 0.030 |
Why?
|
| Phospholipid Ethers | 2 | 2001 | 4 | 0.030 |
Why?
|
| Models, Biological | 2 | 2014 | 1768 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 1999 | 363 | 0.030 |
Why?
|
| Neurons, Afferent | 2 | 1994 | 72 | 0.030 |
Why?
|
| Patient Discharge | 1 | 1998 | 356 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2002 | 307 | 0.030 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1995 | 11 | 0.030 |
Why?
|
| Chlorpheniramine | 2 | 1987 | 2 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 1995 | 39 | 0.030 |
Why?
|
| Thromboxane A2 | 1 | 1995 | 11 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 1995 | 40 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1997 | 346 | 0.030 |
Why?
|
| Chondroitin Sulfates | 1 | 1995 | 43 | 0.030 |
Why?
|
| Cyproheptadine | 1 | 1995 | 9 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1995 | 215 | 0.030 |
Why?
|
| Cat Diseases | 1 | 1995 | 19 | 0.030 |
Why?
|
| Prognosis | 1 | 2003 | 3911 | 0.030 |
Why?
|
| Logistic Models | 1 | 1998 | 1243 | 0.030 |
Why?
|
| Adrenal Glands | 3 | 1982 | 74 | 0.030 |
Why?
|
| Hexamethonium Compounds | 2 | 1987 | 6 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 1995 | 161 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2003 | 1799 | 0.030 |
Why?
|
| Methods | 3 | 1984 | 139 | 0.030 |
Why?
|
| Survival Rate | 1 | 1998 | 1948 | 0.030 |
Why?
|
| Escherichia coli | 2 | 2002 | 563 | 0.030 |
Why?
|
| Cytoplasmic Granules | 1 | 1994 | 94 | 0.030 |
Why?
|
| Chemotaxis | 1 | 1994 | 74 | 0.030 |
Why?
|
| Blood Volume | 1 | 1994 | 42 | 0.030 |
Why?
|
| Rolipram | 2 | 2004 | 2 | 0.030 |
Why?
|
| Clonidine | 2 | 1986 | 33 | 0.030 |
Why?
|
| Pharmaceutical Vehicles | 1 | 1993 | 6 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2014 | 164 | 0.020 |
Why?
|
| L-Selectin | 1 | 1993 | 17 | 0.020 |
Why?
|
| Quinacrine | 1 | 1993 | 10 | 0.020 |
Why?
|
| SRS-A | 1 | 1993 | 27 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1993 | 94 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1993 | 244 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 1993 | 50 | 0.020 |
Why?
|
| Lipoxygenase | 1 | 1993 | 9 | 0.020 |
Why?
|
| Pirenzepine | 1 | 1993 | 6 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 1993 | 52 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2013 | 83 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 253 | 0.020 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2013 | 33 | 0.020 |
Why?
|
| Incidence | 1 | 1997 | 1701 | 0.020 |
Why?
|
| Refusal to Treat | 1 | 1993 | 27 | 0.020 |
Why?
|
| Receptors, Histamine | 2 | 1983 | 4 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 125 | 0.020 |
Why?
|
| Nitroprusside | 2 | 1990 | 25 | 0.020 |
Why?
|
| Erythropoietin | 1 | 1993 | 90 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1993 | 404 | 0.020 |
Why?
|
| Hydrolysis | 2 | 2003 | 141 | 0.020 |
Why?
|
| Pollen | 1 | 1993 | 84 | 0.020 |
Why?
|
| Chickens | 1 | 1993 | 206 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2005 | 58 | 0.020 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2012 | 17 | 0.020 |
Why?
|
| Epothilones | 1 | 2012 | 13 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1993 | 587 | 0.020 |
Why?
|
| Glucose | 1 | 1995 | 692 | 0.020 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2012 | 24 | 0.020 |
Why?
|
| Tubulin Modulators | 1 | 2012 | 23 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 2 | 1983 | 33 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2012 | 47 | 0.020 |
Why?
|
| Chloralose | 1 | 1992 | 5 | 0.020 |
Why?
|
| Endothelium | 1 | 2012 | 59 | 0.020 |
Why?
|
| Benzamides | 1 | 1993 | 246 | 0.020 |
Why?
|
| Cell Line | 2 | 2006 | 2464 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 103 | 0.020 |
Why?
|
| Cohort Studies | 1 | 1999 | 3054 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1993 | 279 | 0.020 |
Why?
|
| Chemokine CXCL2 | 1 | 2012 | 16 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 75 | 0.020 |
Why?
|
| Amides | 1 | 2012 | 54 | 0.020 |
Why?
|
| Amitrole | 1 | 1991 | 3 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2012 | 73 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2012 | 32 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2011 | 27 | 0.020 |
Why?
|
| Adrenalectomy | 2 | 1982 | 44 | 0.020 |
Why?
|
| Permeability | 1 | 2012 | 143 | 0.020 |
Why?
|
| Verapamil | 1 | 1991 | 32 | 0.020 |
Why?
|
| Culture Media | 1 | 1991 | 139 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 254 | 0.020 |
Why?
|
| Chemokines | 1 | 2012 | 76 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 122 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 251 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 1991 | 25 | 0.020 |
Why?
|
| Chronic Disease | 1 | 1995 | 960 | 0.020 |
Why?
|
| Biomarkers | 3 | 2005 | 1910 | 0.020 |
Why?
|
| Acidosis | 2 | 1990 | 53 | 0.020 |
Why?
|
| Cardiac Output | 2 | 1988 | 141 | 0.020 |
Why?
|
| Extracellular Space | 1 | 1991 | 88 | 0.020 |
Why?
|
| Intracellular Membranes | 2 | 2003 | 112 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 1991 | 118 | 0.020 |
Why?
|
| Proteolysis | 1 | 2012 | 123 | 0.020 |
Why?
|
| Uterus | 1 | 1993 | 227 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 379 | 0.020 |
Why?
|
| Anaphylaxis | 1 | 1991 | 30 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 1993 | 268 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 302 | 0.020 |
Why?
|
| Blood | 1 | 1991 | 68 | 0.020 |
Why?
|
| Microcomputers | 1 | 1991 | 25 | 0.020 |
Why?
|
| Histamine H2 Antagonists | 1 | 1991 | 12 | 0.020 |
Why?
|
| Antioxidants | 1 | 2012 | 231 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 125 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 223 | 0.020 |
Why?
|
| Endotoxins | 1 | 1990 | 36 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 1991 | 186 | 0.020 |
Why?
|
| Knee Prosthesis | 1 | 1990 | 24 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2012 | 161 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 178 | 0.020 |
Why?
|
| Genistein | 2 | 2000 | 16 | 0.020 |
Why?
|
| Cold Temperature | 1 | 1990 | 159 | 0.020 |
Why?
|
| Lung Volume Measurements | 2 | 1987 | 24 | 0.020 |
Why?
|
| Hypercapnia | 1 | 1990 | 49 | 0.020 |
Why?
|
| Arthrodesis | 1 | 1990 | 46 | 0.020 |
Why?
|
| Apoptosis | 2 | 2011 | 1721 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 1997 | 1264 | 0.020 |
Why?
|
| Dextrans | 1 | 2010 | 77 | 0.020 |
Why?
|
| Pregnancy | 2 | 1993 | 3147 | 0.020 |
Why?
|
| History, 17th Century | 1 | 1990 | 12 | 0.020 |
Why?
|
| Actin Cytoskeleton | 1 | 2012 | 196 | 0.020 |
Why?
|
| History, 18th Century | 1 | 1990 | 20 | 0.020 |
Why?
|
| Placental Lactogen | 1 | 1970 | 12 | 0.020 |
Why?
|
| Pyridines | 1 | 2012 | 303 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 1996 | 1275 | 0.020 |
Why?
|
| Prolactin | 1 | 1970 | 89 | 0.020 |
Why?
|
| Microcirculation | 1 | 2010 | 98 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 392 | 0.020 |
Why?
|
| History, Ancient | 1 | 1990 | 80 | 0.020 |
Why?
|
| Knee Joint | 1 | 1990 | 161 | 0.020 |
Why?
|
| Electrochemistry | 1 | 1989 | 60 | 0.020 |
Why?
|
| Reference Values | 2 | 1989 | 608 | 0.020 |
Why?
|
| Career Mobility | 1 | 2009 | 37 | 0.020 |
Why?
|
| Locomotion | 1 | 1990 | 145 | 0.020 |
Why?
|
| Respiratory Burst | 2 | 2000 | 19 | 0.020 |
Why?
|
| Extravascular Lung Water | 1 | 2009 | 5 | 0.020 |
Why?
|
| Biological Factors | 1 | 1989 | 18 | 0.020 |
Why?
|
| Glycopeptides | 1 | 1989 | 18 | 0.020 |
Why?
|
| Biological Transport | 2 | 2000 | 404 | 0.020 |
Why?
|
| Aminophylline | 1 | 1989 | 13 | 0.020 |
Why?
|
| Terbutaline | 1 | 1989 | 15 | 0.020 |
Why?
|
| Neurons | 1 | 1997 | 1582 | 0.020 |
Why?
|
| Second Messenger Systems | 1 | 2009 | 39 | 0.020 |
Why?
|
| Anaerobiosis | 1 | 1988 | 20 | 0.020 |
Why?
|
| Radiography | 3 | 1985 | 790 | 0.020 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 1988 | 24 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1989 | 67 | 0.020 |
Why?
|
| Vagina | 1 | 1970 | 177 | 0.020 |
Why?
|
| History, 20th Century | 1 | 1990 | 314 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 537 | 0.020 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 1988 | 18 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 1990 | 313 | 0.020 |
Why?
|
| Blood Pressure | 3 | 1987 | 896 | 0.020 |
Why?
|
| Precipitin Tests | 2 | 1998 | 108 | 0.020 |
Why?
|
| Neuromuscular Junction | 1 | 1988 | 82 | 0.020 |
Why?
|
| Health Priorities | 1 | 1987 | 26 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1987 | 36 | 0.020 |
Why?
|
| Hexamethonium | 1 | 1987 | 4 | 0.020 |
Why?
|
| Functional Residual Capacity | 1 | 1987 | 5 | 0.020 |
Why?
|
| DNA | 1 | 1993 | 1265 | 0.020 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2007 | 9 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2007 | 33 | 0.020 |
Why?
|
| STAT6 Transcription Factor | 1 | 2007 | 29 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2007 | 66 | 0.020 |
Why?
|
| Thromboxanes | 1 | 1986 | 7 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 60 | 0.020 |
Why?
|
| Body Temperature Regulation | 1 | 1986 | 59 | 0.020 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2006 | 17 | 0.020 |
Why?
|
| Carboxylic Acids | 1 | 2006 | 16 | 0.020 |
Why?
|
| Infant | 1 | 1993 | 3220 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 216 | 0.020 |
Why?
|
| Pneumonectomy | 1 | 1988 | 217 | 0.020 |
Why?
|
| Exercise Test | 1 | 1987 | 152 | 0.020 |
Why?
|
| Stroke Volume | 1 | 1988 | 438 | 0.020 |
Why?
|
| Age Factors | 1 | 1991 | 1906 | 0.020 |
Why?
|
| United States Public Health Service | 1 | 1986 | 3 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1986 | 30 | 0.010 |
Why?
|
| Carbon Dioxide | 3 | 1993 | 203 | 0.010 |
Why?
|
| Indoles | 2 | 1998 | 303 | 0.010 |
Why?
|
| Politics | 1 | 1986 | 51 | 0.010 |
Why?
|
| Nerve Block | 1 | 1986 | 51 | 0.010 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2005 | 2 | 0.010 |
Why?
|
| Phentolamine | 1 | 1985 | 8 | 0.010 |
Why?
|
| Chromones | 1 | 2005 | 31 | 0.010 |
Why?
|
| Ethambutol | 1 | 1985 | 6 | 0.010 |
Why?
|
| Protein Kinase C-delta | 1 | 2005 | 29 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2005 | 111 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 555 | 0.010 |
Why?
|
| Morpholines | 1 | 2005 | 61 | 0.010 |
Why?
|
| Nuclear Envelope | 1 | 2005 | 36 | 0.010 |
Why?
|
| Arteries | 2 | 1984 | 171 | 0.010 |
Why?
|
| Rifampin | 1 | 1985 | 22 | 0.010 |
Why?
|
| Plethysmography | 1 | 2004 | 16 | 0.010 |
Why?
|
| Blood Circulation | 1 | 1984 | 29 | 0.010 |
Why?
|
| Drug Therapy | 1 | 1985 | 68 | 0.010 |
Why?
|
| Mutation | 2 | 2010 | 4272 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 308 | 0.010 |
Why?
|
| Chemotactic Factors, Eosinophil | 1 | 2004 | 1 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 1984 | 87 | 0.010 |
Why?
|
| HIV Infections | 1 | 1993 | 961 | 0.010 |
Why?
|
| Neck | 1 | 1984 | 98 | 0.010 |
Why?
|
| Health Surveys | 1 | 1985 | 241 | 0.010 |
Why?
|
| Tritium | 1 | 2003 | 116 | 0.010 |
Why?
|
| Population Surveillance | 1 | 1985 | 213 | 0.010 |
Why?
|
| Adrenergic Fibers | 1 | 1983 | 2 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 729 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 2003 | 49 | 0.010 |
Why?
|
| Serine | 1 | 2003 | 105 | 0.010 |
Why?
|
| Neurokinin A | 2 | 1993 | 12 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 2000 | 1101 | 0.010 |
Why?
|
| Microtomy | 1 | 2002 | 10 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2002 | 43 | 0.010 |
Why?
|
| Receptors, Histamine H1 | 1 | 1982 | 8 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2003 | 264 | 0.010 |
Why?
|
| Phospholipase C beta | 1 | 2001 | 2 | 0.010 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 2001 | 7 | 0.010 |
Why?
|
| Receptors, Cholinergic | 1 | 1982 | 75 | 0.010 |
Why?
|
| Ketones | 1 | 2001 | 14 | 0.010 |
Why?
|
| Phospholipase C gamma | 1 | 2001 | 14 | 0.010 |
Why?
|
| Phosphoinositide Phospholipase C | 1 | 2001 | 6 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2001 | 28 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 291 | 0.010 |
Why?
|
| Respiratory Mucosa | 1 | 2002 | 90 | 0.010 |
Why?
|
| Protein Prenylation | 1 | 2001 | 10 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2002 | 282 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 666 | 0.010 |
Why?
|
| Chelating Agents | 1 | 2001 | 68 | 0.010 |
Why?
|
| Heparitin Sulfate | 1 | 2000 | 28 | 0.010 |
Why?
|
| CD11 Antigens | 1 | 2000 | 14 | 0.010 |
Why?
|
| Hybridomas | 1 | 2000 | 61 | 0.010 |
Why?
|
| Cross Reactions | 1 | 2000 | 113 | 0.010 |
Why?
|
| Tuberculin | 1 | 1979 | 2 | 0.010 |
Why?
|
| Heparin | 1 | 2000 | 181 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1999 | 45 | 0.010 |
Why?
|
| Lipopeptides | 1 | 1999 | 20 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2000 | 167 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2000 | 173 | 0.010 |
Why?
|
| Epitopes | 1 | 1999 | 254 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 1979 | 91 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1999 | 192 | 0.010 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 1979 | 66 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2000 | 287 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1999 | 145 | 0.010 |
Why?
|
| Thromboxane B2 | 1 | 1998 | 11 | 0.010 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 1998 | 20 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2000 | 464 | 0.010 |
Why?
|
| Maleimides | 1 | 1998 | 27 | 0.010 |
Why?
|
| Catalase | 1 | 1998 | 46 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 1997 | 24 | 0.010 |
Why?
|
| Naphthalenes | 1 | 1998 | 40 | 0.010 |
Why?
|
| Myelin Basic Protein | 1 | 1997 | 37 | 0.010 |
Why?
|
| Burns | 1 | 1980 | 149 | 0.010 |
Why?
|
| Receptors, Prostaglandin E, EP1 Subtype | 1 | 1997 | 2 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1922 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1979 | 96 | 0.010 |
Why?
|
| Xanthenes | 1 | 1997 | 22 | 0.010 |
Why?
|
| Ionomycin | 1 | 1997 | 19 | 0.010 |
Why?
|
| Calcimycin | 1 | 1997 | 32 | 0.010 |
Why?
|
| Quinidine | 1 | 1997 | 11 | 0.010 |
Why?
|
| Intradermal Tests | 1 | 1997 | 2 | 0.010 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 1997 | 11 | 0.010 |
Why?
|
| Thapsigargin | 1 | 1997 | 55 | 0.010 |
Why?
|
| Phenylcarbamates | 1 | 1997 | 5 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1997 | 170 | 0.010 |
Why?
|
| Risk | 1 | 1979 | 657 | 0.010 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 1997 | 8 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2000 | 337 | 0.010 |
Why?
|
| Bee Venoms | 1 | 1996 | 4 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 1 | 1977 | 48 | 0.010 |
Why?
|
| Exocytosis | 1 | 1997 | 108 | 0.010 |
Why?
|
| Chlorides | 1 | 1997 | 101 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1996 | 126 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 1997 | 378 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2000 | 603 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1997 | 405 | 0.010 |
Why?
|
| Sodium | 1 | 1997 | 329 | 0.010 |
Why?
|
| Cations | 1 | 1996 | 29 | 0.010 |
Why?
|
| Biopsy | 1 | 1979 | 1175 | 0.010 |
Why?
|
| Miniaturization | 1 | 1995 | 12 | 0.010 |
Why?
|
| Computers | 1 | 1995 | 102 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1999 | 1353 | 0.010 |
Why?
|
| Sulfonamides | 1 | 1997 | 331 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 1994 | 49 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1994 | 38 | 0.010 |
Why?
|
| Liver | 1 | 1979 | 1210 | 0.010 |
Why?
|
| Gases | 1 | 1994 | 31 | 0.010 |
Why?
|
| Humidity | 1 | 1994 | 94 | 0.010 |
Why?
|
| Receptors, Neurokinin-2 | 1 | 1993 | 3 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1999 | 878 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1987 | 3110 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1990 | 493 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1981 | 2802 | 0.010 |
Why?
|
| 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | 1 | 1992 | 4 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1992 | 40 | 0.010 |
Why?
|
| Sheep | 1 | 1992 | 203 | 0.010 |
Why?
|
| Dihydroxyphenylalanine | 1 | 1971 | 14 | 0.010 |
Why?
|
| Tantalum | 1 | 1990 | 5 | 0.010 |
Why?
|
| Femoral Neoplasms | 1 | 1990 | 19 | 0.010 |
Why?
|
| Consumer Behavior | 1 | 1990 | 31 | 0.010 |
Why?
|
| Vasodilation | 1 | 1990 | 91 | 0.010 |
Why?
|
| Tibia | 1 | 1990 | 80 | 0.010 |
Why?
|
| Gait | 1 | 1990 | 83 | 0.000 |
Why?
|
| Pseudopregnancy | 1 | 1970 | 4 | 0.000 |
Why?
|
| Gonadotropins, Pituitary | 1 | 1970 | 11 | 0.000 |
Why?
|
| Anesthesia | 1 | 1992 | 175 | 0.000 |
Why?
|
| Walking | 1 | 1990 | 104 | 0.000 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1989 | 14 | 0.000 |
Why?
|
| Bucladesine | 1 | 1989 | 12 | 0.000 |
Why?
|
| Mice, Inbred Strains | 1 | 1970 | 280 | 0.000 |
Why?
|
| Colforsin | 1 | 1989 | 69 | 0.000 |
Why?
|
| Insulin | 1 | 1994 | 1185 | 0.000 |
Why?
|
| Vagotomy | 1 | 1988 | 12 | 0.000 |
Why?
|
| Ovary | 1 | 1970 | 254 | 0.000 |
Why?
|
| Constriction, Pathologic | 1 | 1988 | 207 | 0.000 |
Why?
|
| Partial Pressure | 1 | 1987 | 49 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1987 | 125 | 0.000 |
Why?
|
| Vital Capacity | 1 | 1987 | 73 | 0.000 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1987 | 106 | 0.000 |
Why?
|
| Karyotyping | 1 | 1987 | 222 | 0.000 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1987 | 102 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1987 | 350 | 0.000 |
Why?
|
| Nursing | 1 | 1985 | 2 | 0.000 |
Why?
|
| Tuberculin Test | 1 | 1985 | 9 | 0.000 |
Why?
|
| Role | 1 | 1985 | 9 | 0.000 |
Why?
|
| Mice, Nude | 1 | 1987 | 824 | 0.000 |
Why?
|
| Prisons | 1 | 1985 | 15 | 0.000 |
Why?
|
| Emigration and Immigration | 1 | 1985 | 49 | 0.000 |
Why?
|
| Employment | 1 | 1985 | 54 | 0.000 |
Why?
|
| Canada | 1 | 1985 | 194 | 0.000 |
Why?
|
| Adhesiveness | 1 | 1984 | 4 | 0.000 |
Why?
|
| Carbon Radioisotopes | 1 | 1984 | 34 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1984 | 144 | 0.000 |
Why?
|
| False Negative Reactions | 1 | 1984 | 59 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1984 | 293 | 0.000 |
Why?
|
| Nursing Homes | 1 | 1985 | 110 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1988 | 754 | 0.000 |
Why?
|
| Polyethylene Glycols | 1 | 1984 | 373 | 0.000 |
Why?
|
| Laryngeal Nerves | 1 | 1980 | 3 | 0.000 |
Why?
|
| Efferent Pathways | 1 | 1980 | 22 | 0.000 |
Why?
|
| Reflex | 1 | 1980 | 80 | 0.000 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 1980 | 18 | 0.000 |
Why?
|
| Asphyxia | 1 | 1980 | 12 | 0.000 |
Why?
|
| Smoke | 1 | 1980 | 29 | 0.000 |
Why?
|
| Fires | 1 | 1980 | 22 | 0.000 |
Why?
|
| Larynx | 1 | 1980 | 35 | 0.000 |
Why?
|
| Pulmonary Edema | 1 | 1980 | 53 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1988 | 7061 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1985 | 3829 | 0.000 |
Why?
|
| Pulmonary Embolism | 1 | 1980 | 226 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1988 | 10164 | 0.000 |
Why?
|
| Posture | 1 | 1971 | 123 | 0.000 |
Why?
|